Macro Group Pharmaceuticals (Macro Capital) S.A.E (EGX:MCRO)
Egypt · Delayed Price · Currency is EGP 1.460
+0.090 (6.57%)
At close: Feb 23, 2026
EGX:MCRO Revenue
In the year 2025, Macro Group Pharmaceuticals (Macro Capital) S.A.E had annual revenue of 894.54M EGP with 72.04% growth. Macro Group Pharmaceuticals (Macro Capital) S.A.E had revenue of 216.28M in the quarter ending December 31, 2025, with 7.73% growth.
Revenue
894.54M
Revenue Growth
+72.04%
P/S Ratio
0.93
Revenue / Employee
n/a
Employees
n/a
Market Cap
832.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 894.54M | 374.58M | 72.04% |
| Dec 31, 2024 | 519.97M | -6.04M | -1.15% |
| Dec 31, 2023 | 526.01M | -203.61M | -27.91% |
| Dec 31, 2022 | 729.61M | 135.35M | 22.78% |
| Dec 31, 2021 | 594.26M | 163.76M | 38.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition